The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer. The combination of immunotherapy…
-
-
HealthDay Reporter TUESDAY, Dec. 13, 2016 (HealthDay News) — An immunotherapy drug called Tecentriq (atezolizumab) extended the survival of lung cancer patients…
